Back to top
more

Organon & Co. (OGN)

(Delayed Data from NYSE)

$20.88 USD

20.88
1,723,323

+0.96 (4.82%)

Updated Jul 11, 2024 04:00 PM ET

After-Market: $20.89 +0.01 (0.05%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth B Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (99 out of 250)

Industry: Medical Services

Better trading starts here.

Zacks News

Organon (OGN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Organon (OGN) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Should WisdomTree U.S. SmallCap Dividend ETF (DES) Be on Your Investing Radar?

Style Box ETF report for DES

Is WisdomTree U.S. SmallCap Dividend ETF (DES) a Strong ETF Right Now?

Smart Beta ETF report for DES

Organon (OGN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

While the top- and bottom-line numbers for Organon (OGN) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Viatris (VTRS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Viatris (VTRS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Organon (OGN) to Report a Decline in Earnings: What to Look Out for

Organon (OGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Life Time Group Holdings, Inc. (LTH) Q3 Earnings Match Estimates

Life Time Group Holdings, Inc. (LTH) delivered earnings and revenue surprises of 0% and 0.16%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?

Organon (OGN) Reports Q2 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Organon (OGN) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Organon (OGN) Q2 Earnings and Revenues Beat Estimates

Organon (OGN) delivered earnings and revenue surprises of 35.05% and 3.10%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Sotera Health Company (SHC) Tops Q2 Earnings Estimates

Sotera Health Company (SHC) delivered earnings and revenue surprises of 16.67% and 2.21%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

Organon (OGN) Reports Q1 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Organon (OGN) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Organon (OGN) Lags Q1 Earnings Estimates

Organon (OGN) delivered earnings and revenue surprises of -8.47% and 1.33%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Establishment Labs Holdings Inc. (ESTA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Establishment Labs Holdings Inc. (ESTA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Organon (OGN) to Report a Decline in Earnings: What to Look Out for

Organon (OGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Organon (OGN) Q4 Earnings and Revenues Miss Estimates

Organon (OGN) delivered earnings and revenue surprises of -4.71% and 1.04%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Will Organon (OGN) Beat Estimates Again in Its Next Earnings Report?

Organon (OGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Organon (OGN) Q3 Earnings and Revenues Top Estimates

Organon (OGN) delivered earnings and revenue surprises of 17.86% and 2.94%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Earnings Preview: InnovAge Holding Corp. (INNV) Q1 Earnings Expected to Decline

InnovAge Holding Corp. (INNV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Analysts Estimate Organon (OGN) to Report a Decline in Earnings: What to Look Out for

Organon (OGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Is WisdomTree U.S. MidCap ETF (EZM) a Strong ETF Right Now?

Smart Beta ETF report for EZM

Should WisdomTree U.S. MidCap ETF (EZM) Be on Your Investing Radar?

Style Box ETF report for EZM

New Strong Sell Stocks for August 8th

COWN, AUD, and OGN have been added to the Zacks Rank #5 (Strong Sell) List on August 8, 2022.

Organon (OGN) Surpasses Q2 Earnings and Revenue Estimates

Organon (OGN) delivered earnings and revenue surprises of 7.76% and 5.40%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Analysts Estimate Viatris (VTRS) to Report a Decline in Earnings: What to Look Out for

Viatris (VTRS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: Organon (OGN) Q2 Earnings Expected to Decline

Organon (OGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.